Stockreport

Recursion Pharmaceuticals CEO explains how AI could make drug development faster and less costly [CNBC]

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF his company is using artificial intelligence and machine learning to make the process of developing drugs faster and less expensive. Recursion Pharmaceuticals is a cli [Read more]